A More Connected Path Forward for Complex Depression
Ketamine has helped many people with severe or treatment-resistant depression experience meaningful relief when medications and therapy have not provided enough improvement. For some, the shift can feel profound and may appear more quickly than it does with traditional antidepressants. Still, ketamine-assisted therapy is not a stand-alone answer or a guaranteed fix. At Resova Infusions & TMS, we look at the full clinical picture before recommending advanced treatment. Our physician-led team considers your diagnosis, symptoms, medication history, previous treatment response, safety concerns, and personal goals. Care is overseen by a psychiatrist. Rapid improvement is possible, but it is not universal. The strength and length of benefit can vary widely, which is why thoughtful evaluation, monitoring, and follow-up matter just as much as the treatment itself. A strong plan also addresses what happens between treatments and after an initial series ends.How Ketamine-Assisted Therapy Fits Psychiatric Care
Ketamine-assisted therapy is a structured clinical approach, not simply an infusion. We begin with psychiatric evaluation, determine whether ketamine is appropriate, provide monitored treatment, and help you use any changes in mood, perspective, or daily function as part of a broader care plan. Ketamine affects glutamate signaling in the brain and may support neuroplasticity, which is the brain’s ability to form and strengthen new connections. Research has shown antidepressant effects within hours to days for some people, especially those living with treatment-resistant depression. That faster response can create an important opening, particularly when depression has made it hard to engage in daily life or therapy. Treatment choices require clinical judgment. IV ketamine is used off label for depression. Spravato, an esketamine nasal spray, is FDA approved for certain adults with treatment-resistant depression and is administered with monitoring. We consider several factors before deciding which approach may fit:- Your psychiatric diagnosis and current symptoms
- Prior medication trials and treatment response
- Medical history and medication use
- Safety concerns, recovery needs, and treatment goals
Building Safety and Readiness Before Treatment
Before ketamine treatment begins, careful screening helps us determine whether it is appropriate and how to provide it safely. A psychiatrist should review mood symptoms, current medications, substance use history, medical conditions, previous psychiatric care, and any concerns that could affect treatment. Ketamine may be relevant for some people with major depressive disorder, bipolar depression, severe anxiety symptoms, trauma-related symptoms, or chronic suicidal thinking when standard approaches have not led to enough improvement. Yet a diagnosis alone does not determine candidacy. It is not the right fit for every person or every circumstance. Preparation also helps set realistic expectations. Some people notice meaningful relief after treatment, while others have a smaller response or no meaningful response. We discuss what treatment may feel like, what recovery after an infusion involves, and how progress will be monitored over time. Monitored care should include:- Treatment in a clinical setting with medical oversight
- Observation during and after the infusion
- Physical monitoring, including blood pressure when appropriate
- A transportation and recovery plan after treatment
- Clear communication about symptoms or side effects